COMP <GO>
ALXO vs DERM // EV/EBITDA & P/E VALUATION
ALX Oncology Holdings Inc. (NASDAQ) VS. Journey Medical Corporation (NASDAQ) • 15-METRIC TALLY: ALXO 1
— DERM 3
■ METRIC PARITY
LAST: $1.22 (0.00%) • MKT CAP: $152.4M
valuation
—
LAST: $5.17 (-4.44%) • MKT CAP: $152.7M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALXO VS. DERM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALXO | DERM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 65.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -19.50% | -15.50 | DERM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -8.15% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -13.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -18.70% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 11.10% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.74 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | DERM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.4 | 40.5 | +6.98 | ALXO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $152.4M | $152.7M | -$287.2K | DERM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALXO REV | DERM REV | ALXO GROSS % | DERM GROSS % | ALXO FCF | DERM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $61.2M | — | 65.8% | -$84.4M | -$12.4M |
| FY 2024 | $0 | $55.1M | — | 62.1% | -$122.4M | -$9.1M |
| FY 2023 | $0 | $59.7M | — | — | -$130.4M | $5.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALXO // BETA —
DERM // BETA —